GCT Semiconductor (GCTS) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
16 Dec, 2025Company overview and business model
Fabless semiconductor company specializing in high-speed wireless communication chipsets, including 5G/4G transceivers and modems for industrial, B2B, and consumer applications.
Operations include R&D in South Korea and sales/support offices in Taiwan, China, and Japan, with headquarters in San Jose, California.
Product portfolio covers LTE, LTE Advanced, LTE Advanced-Pro, and cellular IoT chipsets for various wireless and IoT applications.
Financial performance and metrics
Identified as a smaller reporting company with less than $250 million in public float or less than $100 million in annual revenue.
Most recent closing price for common stock was $1.65 per share, and $0.07 per public warrant as of May 12, 2025.
Financial statements for the two most recent years are incorporated by reference, with a going concern explanatory paragraph from the auditor.
Use of proceeds and capital allocation
May receive up to $103.3 million if all warrants are exercised for cash; proceeds intended for general corporate purposes, including working capital, capex, and acquisitions.
Proceeds are contingent on warrant exercise, which depends on the market price exceeding exercise prices; no assurance of any proceeds.
Latest events from GCT Semiconductor
- Q2 revenue fell as 4G sales dropped, but 5G partnerships and funding drive future growth.GCTS
Q2 20242 Feb 2026 - Poised for 5G-driven growth in FWA and broadband, with new chipsets sampling by year-end.GCTS
2024 Annual Gateway Conference22 Jan 2026 - Gross margin soared to 62% as 5G ramp nears and capital-raising efforts intensify.GCTS
Q3 202413 Jan 2026 - Profitability expected in Q4 2025 as 5G chipsets drive growth and industry consolidation benefits.GCTS
Sidoti Small-Cap Virtual Investor Conference11 Jan 2026 - 5G chipset launch and new partnerships set stage for transformative growth in 2025.GCTS
Q4 202426 Dec 2025 - Large-scale resale and warrant exercises may cause dilution and price pressure, with proceeds uncertain.GCTS
Registration Filing16 Dec 2025 - Up to 10.9M shares registered for resale under a $50M equity facility, enabling flexible funding.GCTS
Registration Filing16 Dec 2025 - Up to $200M in securities registered, including $75M at-the-market stock, for broad corporate use.GCTS
Registration Filing16 Dec 2025 - Over 62M shares and 6.7M warrants registered, with proceeds dependent on warrant exercise.GCTS
Registration Filing16 Dec 2025